Drug or technology
5 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 4, 2026 · PHASE 1/2 TRIAL
ClinicalTrials.gov
This is a clinical trial registry record describing a planned Phase 1b/2 study with no results reported; it documents the protocol and design only.
SEP 4, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
Phase 1b/II dose-escalation trial with planned enrollment and no results yet reported in this registry record; early-phase design focused on safety and maximum tolerated dose.
AUG 17, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a registry record for an actively recruiting Phase 1b/3 trial with no results posted; it describes study design and planned enrollment only.
AUG 17, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a clinical trial registry record describing an active Phase 3 study with no results yet posted; the trial is ongoing and no efficacy or safety data are available for analysis.
AUG 3, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1b registry record with no posted results; it describes a planned safety and tolerability study of combination therapies in HER2-low metastatic breast cancer with no efficacy data yet reported.